Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating the Protective Efficacy, Immunogenicity, and Safety of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine in Infants and Children Aged 6 Months to 5 Years in Bangladesh

NCT06838195 is registered in ClinicalTrials.gov with Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd as lead sponsor.

NCT NCT06838195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06838195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating the Protective Efficacy, Immunogenicity, and Safety of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine in Infants and Children Aged 6 Months to 5 Years in Bangladesh
Lead sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 12, 2025
Completion date
July 30, 2028
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysentery, dysentery, shigella